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Antunes-Correa LM, Nobre TS, Groehs RV, Alves MJ, Fer-
nandes T, Couto GK, Rondon MU, Oliveira P, Lima M, Mathias
W, Brum PC, Mady C, Almeida DR, Rossoni LV, Oliveira EM,
Middlekauff HR, Negrao CE. Molecular basis for the improvement
in muscle metaboreflex and mechanoreflex control in exercise-trained
humans with chronic heart failure. Am J Physiol Heart Circ Physiol
307: H1655–H1666, 2014. First published October 10, 2014;
doi:10.1152/ajpheart.00136.2014.—Previous studies have demon-
strated that muscle mechanoreflex and metaboreflex controls are
altered in heart failure (HF), which seems to be due to changes in
cyclooxygenase (COX) pathway and changes in receptors on afferent
neurons, including transient receptor potential vanilloid type-1
(TRPV1) and cannabinoid receptor type-1 (CB1). The purpose of the
present study was to test the hypotheses: 1) exercise training (ET)
alters the muscle metaboreflex and mechanoreflex control of muscle
sympathetic nerve activity (MSNA) in HF patients. 2) The alteration
in metaboreflex control is accompanied by increased expression of
TRPV1 and CB1 receptors in skeletal muscle. 3) The alteration in
mechanoreflex control is accompanied by COX-2 pathway in skeletal
muscle. Thirty-four consecutive HF patients with ejection fractions
40% were randomized to untrained (n  17; 54  2 yr) or
exercise-trained (n  17; 56  2 yr) groups. MSNA was recorded by
microneurography. Mechanoreceptors were activated by passive ex-
ercise and metaboreceptors by postexercise circulatory arrest (PECA).
COX-2 pathway, TRPV1, and CB1 receptors were measured in
muscle biopsies. Following ET, resting MSNA was decreased com-
pared with untrained group. During PECA (metaboreflex), MSNA
responses were increased, which was accompanied by the expression
of TRPV1 and CB1 receptors. During passive exercise (mechanore-
flex), MSNA responses were decreased, which was accompanied by
decreased expression of COX-2, prostaglandin-E2 receptor-4, and
thromboxane-A2 receptor and by decreased in muscle inflammation,
as indicated by increased miRNA-146 levels and the stable NF-B/
IB- ratio. In conclusion, ET alters muscle metaboreflex and mecha-
noreflex control of MSNA in HF patients. This alteration with ET is
accompanied by alteration in TRPV1 and CB1 expression and COX-2
pathway and inflammation in skeletal muscle.
heart failure; muscle sympathetic nervous system; metaboreflex;
mechanoreflex; exercise training
NEUROHUMORAL EXCITATION, INCLUDING activation of the sympa-
thetic nervous system, is prevalent in chronic heart failure (HF)
patients with systolic dysfunction (11, 15, 17, 19, 54). Sym-
pathetic nerve activity (SNA), whether measured indirectly by
plasma norepinephrine levels (11), norepinephrine spillover
(15), or decreased heart rate (HR) variability (17) or directly by
microneurographic recordings (19), is found to be elevated.
Furthermore, HF patients with the greatest sympathetic activa-
tion have the poorest prognosis (4, 11).
The mechanisms underlying this increased resting muscle
sympathetic nerve activity (MSNA) in HF are likely multiple
and diverse. Potential mechanisms include primary central
neural dysregulation, and/or abnormal peripheral reflex regu-
lation of central sympathetic outflow [reviewed by Zucker et
al. (54)]. Not only is resting MSNA elevated in HF, but
neurovascular responses during exercise are also augmented
and may contribute to exercise dysfunction (13, 18, 23, 24, 32,
34). HR and blood pressure (BP) are regulated during exercise
by the exercise pressor reflex, in which signals from muscle
afferents, including muscle metaboreceptors and mechanore-
ceptors, reflexively control MSNA. Muscle metaboreceptors
are unmyelinated group IV fibers, which are sensitive to
ischemic metabolites generated during exercise, and muscle
mechanoreceptors are thinly myelinated, group III fibers sen-
sitive to mechanical stimuli, such as stretch (16, 27). The group
of Sinoway (41) was the first to report that muscle metabore-
flex control of MSNA during exercise is blunted in patients
with chronic HF. Conversely, the muscle mechanoreflex is
augmented in patients with HF and is sensitized by cyclooxy-
genase (COX) products, but not lactic acid or adenosine,
generated during exercise (21, 22).
Investigations in the rat-infarct model of HF, in which it is
possible to make direct electrophysiologic recordings from
group III and IV afferents, have confirmed and extended these
findings in humans with HF (45). Interestingly, COX-2 expres-
sion is augmented in skeletal muscle of HF rats, and COX-2
inhibition attenuates the exaggerated mechanoreflex control,
confirming the findings in humans with HF (21, 29). Recent
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findings suggest that miRNAs, including miRNA-16 and
miRNA-143, may modulate the COX-2 protein expression
(28). In addition, the miRNA-146 has been predicted to target
nuclear factor-B (NF-B), an important modulator of COX-2
expression (28, 37). Conversely, with the use of direct electro-
physiologic recordings from group IV muscle metaboreceptors
in HF rats, afferent neuronal firing in response chemical
agonists was blunted, confirming the findings in humans with
HF (45). Transient receptor potential vanilloid type-1 (TRPV1)
receptors and cannabinoid type-1 (CB1) receptors are colocal-
ized on group IV afferent neurons and, when stimulated,
increase efferent MSNA. In animal models of HF, decreased
expression of TRPV1 in dorsal root ganglia (DRG), accompa-
nied by decreased afferent responsiveness to TRPV1 agonists,
has been reported (40, 45, 49). The mechanisms underlying
these multiple abnormalities of the primary afferent neurons in
the rat-infarct model of HF remain speculative, but impor-
tantly, they are preventable with exercise training (46, 47).
Exercise training has been shown to improve exercise ca-
pacity and quality of life in humans with HF (31, 33). In
addition, exercise training leads to a remarkable reduction in
resting MSNA in HF patients regardless of age, gender, and
presence of sleep apnea (1, 2, 36, 43). Furthermore, the impact
of exercise training on sympathetic responses during exercise
in HF has not been studied. The mechanisms underlying the
reduction in resting MSNA following training in humans with
HF remain poorly understood. The purpose of these studies in
patients with chronic HF was to test the following hypotheses:
1) exercise training alters the muscle metaboreflex and the
mechanoreflex control of MSNA in patients with chronic HF.
2) The alteration in metaboreflex control is accompanied by
increased expression of TRPV1 and CB1 receptors in skeletal
muscle biopsy [vastus lateralis (VL)]. In addition, 3) the
alteration in mechanoreflex control is accompanied by changes
in the COX-2 pathway in VL muscle biopsy from exercise-
trained patients with HF compared with untrained control HF
patients.
METHODS
Study Population
Consecutive HF outpatients [age 30 to 65 yr, functional class II to
III of New York Heart Association, ejection fraction 40%, and peak
oxygen uptake (V˙ O2) 20 ml·kg1·min1] were invited to participate
in the study. The exclusion criteria were recent myocardial infarction
or unstable angina (3 mo), HF duration 3 mo, permanent pace-
maker dependence, atrial fibrillation, participation in a regular exer-
cise program, or musculoskeletal disorder (e.g., arthritis) prohibiting
participation in exercise training. The study was approved by Human
Subject Protection Committee of the Heart Institute (InCor; SDC-3083/
07/158) and Clinical Hospital, University of Sao Paulo Medical School
(CAPPesq-0020/08). All subjects gave written informed consent to par-
ticipate in the study. The trial is registered at www.ClinicalTrials.gov
(NCT01884142).
Measures and Procedures
Cardiopulmonary exercise testing. Cardiopulmonary exercise test-
ing was conducted at baseline and after 4 mo of exercise training or
untrained control period, as previously described (2, 10, 43). Maximal
exercise capacity was determined during a maximal progressive
exercise test on cycle ergometer (Ergoline, Spirit 150), using a ramp
protocol with work rate increments of 5–10 W every minute until
exhaustion. V˙ O2 and carbon dioxide production were determined by
means of gas exchange on a breath-by-breath basis in a computerized
system (Model Vmax 229; Sensor Medics, Buena Vista, CA). Peak
V˙ O2 was defined as the maximum attained V˙ O2 at the end of the
exercise period in which the subject could no longer maintain the
cycle ergometer velocity at 60 rpm. Anaerobic threshold was identi-
fied at the breakpoint between the increase in the carbon dioxide
output and V˙ O2 (V slope) or at the point in which the ventilatory
equivalent for oxygen and end-tidal oxygen partial pressure curves
reached their respective minimum values and began to rise. Respira-
tory compensation was identified at the point at which ventilatory
equivalent for carbon dioxide was lowest before a systematic increase
and when end-tidal carbon dioxide partial pressure reaches a maxi-
mum value and begins to decrease (38).
Muscle sympathetic nerve activity. MSNA was directly measured
from the peroneal nerve in the nonexercising limb (right leg) using the
technique of microneurography, as previously described (44a). In
brief, signals were amplified by a factor of 50,000 to 100,000 and
band-passed filtered (700 to 2,000 Hz). For recordings and analysis,
nerve activity was rectified and integrated (time constant: 0.1 s) to
obtain a mean voltage display. Muscle sympathetic bursts were
identified by visual inspection by the principal investigator and by two
other investigators (C. E. Negrao and M. U. Rondon) blinded to the
study protocol. MSNA was expressed as total activity (arbitrary
units), burst frequency (bursts/min), and burst incidence (bursts/100
heartbeats).
Muscle mechanoreflex sensitivity. Passive leg exercise, which elim-
inates activation of central command and the metaboreceptors, was
used to activate muscle mechanoreceptors. Passive exercise was
performed by flex/extension of the knee joint on the left leg, 30
times/min by the principal investigator. Visual and manual inspection
of the VL muscle was conducted to ensure that this maneuver resulted
in muscle length changes to stimulate mechanoreceptors. Mechanore-
flex sensitivity was calculated as the difference in percentage change
in MSNA, BP, and HR between peak passive exercise and rest
periods.
Muscle metaboreflex sensitivity. Postexercise regional circulatory
arrest (PECA), which eliminates the activation of central command
and muscle mechanoreceptors, was used to isolate muscle metabore-
ceptors. The maximum voluntary contraction (MVC) was calculated
by averaging the maximum load achieved in three consecutive repe-
titions, measured using a dynamometer (DLC-model, Dynamometer;
Kratos, Sao Paulo, SP, Brazil). Just before release of 3 min of 30%
MVC exercise, the circulation to the exercising leg was arrested by
inflating the thigh occlusion cuff (240 mmHg) for 2 min, followed by
3 min of recovery. The isometric contraction of the quadriceps
stimulates the production of metabolites and muscle changes similar
to those caused by moderate physical exercise. Metaboreflex sensi-
tivity was calculated as the difference in percentage change in MSNA,
BP, and HR between peak exercise or the first minute of PECA in
relation to rest period.
Other measurements. Left ventricular ejection fraction (LVEF) was
determined from the two-dimensional echocardiography by Simpson
method (IE33; Philips Medical Systems, Andover, MA). HR, systolic,
and diastolic and mean BP were monitored noninvasively with an
oscillometric beat-to-beat device (FinometerPro; Finapress Medical
Systems, Amsterdam, The Netherlands).
Skeletal muscle biopsy. Percutaneous muscle biopsy procedures
were performed in VL, approximately at the midway point between
top edge of the patella and the greater trochanter. With the use of a
sterile technique, and after ensuring adequate local anesthesia, a small
incision was made in the skin and subcutaneous tissue. A 5-mm
modified Allendale-Bergstrom needle was then inserted through the
fascia, and an assistant immediately applied suction by using a syringe
connected to a canister and attached to the top of the needle (30). The
muscle sample was immediately frozen in liquid nitrogen and subse-
quently stored in a freezer at 80°C.
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mRNA and miRNA analysis by real-time polymerase chain
reaction. Frozen muscle samples (30 mg) were homogenized in
Trizol and RNA was isolated, according to the manufacturer’s instruc-
tions (Invitrogen Life Technologies). After extraction, the total RNA
concentration was quantified using a NanoDrop Spectrophotometer
(Nano-Drop Technologies) and checked for integrity by EtBr-agarose
gel electrophoresis. RNA were primed with 0.5 	g/	l oligo dT
(Fermentas/Thermo Scientific Molecular Biology) to generate first-
strand DNA. Reverse transcription (RT) was performed using Rever-
taid M-MuLV Reverse Transcriptase (Fermentas/Thermo Scientific
Molecular Biology). cDNA for miRNA analysis was synthesized from
total RNA using gene-specific primers according to the TaqMan
MicroRNA Assay protocol (Applied Biosystems). Real-time quanti-
fication of the COX-1, COX-2, mPGES1, PGIS, TXAS, EP1, EP2,
EP3, EP4, IP, TP, TRPV1, and CB1 mRNA was performed with a
SYBRGreen PCR Master Mix, using ABI PRISM 7700 Sequence
Detection System (Applied Biosystem). The expression of cyclophilin
was measured as an internal control for sample variation in RT
reaction. Cyclophilin was chosen as the internal control because of its
homogeneous expression among different samples (efficiency% 
95.04; P  0.28). In addition, cyclophilin showed better condition
than other internal controls (GAPDH and 18S). Primers were
designed using Primer 3 software (http://primer3plus.com/cgi-
bin/dev/primer3plus.cgi). The DNA sequence was obtained from
GenBank, and primers were made in separate exons to distinguish
PCR products derived from cDNA by size from those derived from
genomic DNA contaminants. To accurately detect miRNA-16 (INV
0391), miRNA-143 (INV 0466), and miRNA-146 (INV 0468), the
real-time PCR quantification method was performed using TaqMan
MicroRNA Assay protocol (Applied Biosystems). MiRNAs samples
were normalized by evaluating U6 expression. Each muscle sample
was analyzed in duplicate. Relative quantities of target gene expres-
sions of untrained group vs. exercise-trained group were compared
after normalization to the values of reference gene (
CT). Fold
changes in mRNA and miRNA expression were calculated using the
differences in 
CT values between the two samples (

CT) and
equation 2

CT. Results are expressed as percentage of control.
Western blot. Frozen muscles samples were homogenized in cold
RIPA lysis buffer (Upstate) containing protease inhibitor cocktail
(1:5,000 dilution; Sigma), sodium fluoride (100 mM), sodium pyro-
phosphate (10 mM), sodium orthovanadate (100 mM), and PMSF (10
mM). Then, homogenates were centrifuged (12,000 rpm for 30 min at
4°C), and supernatants were isolated. Protein extracts (50 	g) were
electrophoretically separated using 7.5% SDS-PAGE and then trans-
ferred to PVDF membranes (Amersham-GE Healthcare) overnight at
4°C using a Mini Trans-Blot Cell system (Bio-Rad) containing trans-
fer buffer (25 mM Tris, 190 mM glycine, 20% methanol, and 0.05%
SDS) as described previously (8, 48). After blockade of nonspecific
sites with 5% nonfat dried milk, membranes were incubated overnight
at 4°C with the primary antibody against rabbit anti-COX-2 (1:1,000
dilution; Cayman Chemical), rabbit anti-NF-B p65 (1:1,000; Santa
Cruz Biotechnology), and rabbit anti-IB- (1:1,000; Santa Cruz
Biotechnology). Membranes were washed and then incubated for 2 h
at room temperature with peroxidase-conjugated anti-rabbit IgG an-
tibody (Bio-Rad) for COX-2 (1:7,000 dilution), NF-B p65 (1:1,500
dilution), and IB- (1:1,500 dilution). Membranes were thoroughly
washed, and immunocomplexes were detected using an enhanced
horseradish peroxidase/luminal chemiluminescence system (ECL
Plus; Amersham-GE Healthcare) and subjecting the membrane to
autoradiography (Hyperfilm ECL; Amersham-GE Healthcare). The
same membrane was then stripped and used to determine sarcomeric
actin protein expression as an internal control using a monoclonal
mouse anti-sarcomeric actin antibody (1:1,000 dilution; Dako). Im-
munoblots signals were quantified using Scion Image (Scioncorp;
National Institutes of Health).
COX-2 considerations. It is widely recognized that COX-2 is a
72-kDa protein (48); however, in human skeletal muscle samples, the
COX-2 band is not detected in 72 kDa and appears to be 10 kDa
smaller in size than 72 kDa (6). In line with Burd et al. (6), we
quantified the COX-2 protein bands near to 62 kDa.
Exercise training program. The exercise training protocol was
conducted for 4 mo, as previously described (1, 2, 9, 10, 43). In brief,
it consisted of three 60-min exercise sessions/week. Each exercise
session consisted of 5-min stretching exercises, 30 min of cycling on
an ergometer bicycle in the first 15 days and up to 40 min in the rest
of the period, 10 min of local strengthening exercises, and 5 min of
cool down with stretching exercises. The exercise intensity was
established by HR levels that corresponded to anaerobic threshold
up to 10% below the respiratory compensation point obtained in
the cardiopulmonary exercise test. This intensity corresponded to
60 –72% peak V˙ O2. In four patients, the respiratory compensation
point was not detectable. In those patients, the exercise training
was determined at the anaerobic threshold. During the exercise
sessions, when a training effect was observed, as indicated by a
decrease by 8 to 10% in HR, the bicycle work rate was increased
by 0.25 or 0.5 kpm to return to the target HR levels. Subjects
underwent exercise training under supervision at the Heart Insti-
tute. The untrained patients were instructed to avoid any regular
exercise program. The patients were asked about exercise each
visit to the outpatient clinic (approximately every 3 or 4 wk). After
the end of the protocol, the untrained patients were invited to
participate in the exercise training program.
Experimental Protocol
The experimental protocol (Fig. 1) was performed in a thermoneu-
tral room at approximately the same time of day. The subject was
placed in the supine position, and electrocardiogram leads were placed
on the chest. The cuffs for BP measurement were placed on the left
arm. The left leg was positioned on a support with 150° inclination,
and the occlusion cuff used during PECA was placed on the left thigh.
The right leg was positioned for microneurography, and an adequate
nerve-recording site was obtained. Then the subjects rested for 10 min, and
then mechanoreflex sensitivity evaluation was initiated. Ten minutes
after the end of the mechanoreflex sensitivity evaluation, muscle
metaboreflex sensitivity evaluation was initiated. The skeletal muscle
biopsy was performed between 3 and 7 days after mechano- and
metaboreflex studies. The experimental protocol and skeletal muscle
biopsy were repeated before and after 4 mo of exercise training or
clinical follow up, 24–48 h after the last exercise training session.
Patients were instructed to continue cardiac medications throughout
the study.
Instrumentation 10 min 3 min  
rest 
3 min  
PE 
3 min  
recovery 
10 min 3 min  
rest 
3 min  
IE 
2 min  
PECA 
3 min  
recovery 
Muscle mechanoreflex sensitivity Muscle metaboreflex sensitivity
Fig. 1. Experimental protocol. PE, passive exercise; IE, isometric exercise; PECA, postexercise regional circulatory arrest.
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Statistical Analysis
The data are presented as means SE. The Kolmogorov-Smirnov and
Levene’s test were used to assess the normality of distribution and
homogeneity for each variable. Parametric tests were used for variables
with normal distribution and homogeneity. The baseline characteristics
among groups (dropout, untrained, and exercise trained) were tested by
one-way ANOVA. Differences in the resting neurovascular and hemo-
dynamic parameters between groups before and after exercise training
and untrained time control were verified by two-way ANOVA for
repeated measures. The responses (percentage changes) to 30% isometric
exercise and passive exercise before and after exercise training and
untrained time control were tested by two-way ANOVA for repeated
measures. Similarly, the responses during metaboreceptors stimulation
(percentage changes; PECA vs. rest) before and after exercise training
and untrained time control were tested by two-way ANOVA for repeated
measures. Two-way ANOVA for repeated measures was also used to test
whether the changes in the neurovascular and hemodynamic parameters
during 30% isometric exercise and PECA and during passive exercise
reached significance levels. This analysis was done before and after
exercise training and untrained time control. In case of significance,
Scheffé’s post hoc multiple comparisons were conducted. For variables
with no normal distribution and homogeneity, nonparametric tests were
used (Mann-Whitney’s test and Wilcoxon’s test). A Chi-square (2) test
was used to assess categorical data differences. Probability values of P
0.05 were considered statistically significant.
RESULTS
Study Population
Fifty-six consecutive HF patients were randomized into two
groups: 1) untrained time control group (n  28), and 2)
exercise-trained group (n  28). In the untrained group, 11
patients did not complete the time control period because of HF
decompensation or myocardial infarction (n  4), noncardio-
vascular events (n  2), death (n  1), and drop out for
personal reasons (n  4). In the exercise-trained group, 11
patients did not complete the training protocol because of HF
decompensation or myocardial infarction (n  3), noncardio-
vascular events (n  3), death (n  1), and drop out for
personal reasons (n  4). Thus data are available for analysis
in 34 subjects. Baseline characteristics of the HF patients who
completed the time control period (n  17), completed exer-
cise training (n  17), and the dropout patients (n  22) are
shown in Tables 1 and 2. There were no differences among the
groups in any of the parameters measured.
Effects of Exercise Training on resting Neurovascular and
Hemodynamic Parameters
The effects of exercise training on resting neurovascular and
hemodynamic parameters are shown in Table 2. LVEF and
resting hemodynamic parameters were unchanged in exercise-
trained group. However, exercise training significantly increased
peak V˙ O2 and led to a significant reduction in resting MSNA.
Exercise capacity, LVEF, HR, BP, and neurovascular parameters
were unchanged in the untrained time control HF patients.
Effects of Exercise Training on Neurovascular and
Hemodynamic Parameters During Isometric Exercise Testing
During peak 30% MVC isometric leg exercise at baseline,
MSNA increased significantly and similarly in both exercise-
trained and untrained HF groups (Fig. 2). Likewise, the in-
crease in BP and HR was similar between groups (Table 3).
Significant artifact obscured the sympathetic neurogram in one
exercise-trained patient during the last 30 s of 30% MVC
isometric leg exercise, so only the 30 s before the motor neuron
signals were analyzed. One HF patient was excluded from this
study because he had arrhythmias during this study, which
significantly altered the MSNA pattern.
Following exercise training, the MSNA increased during peak
30% MVC isometric leg exercise, and the increase was signifi-
cantly greater compared with the increase in MSNA in the
untrained time control HF group (Fig. 2). Surprisingly, following
exercise training, despite the augmented MSNA responses during
Table 1. Baseline characteristics in patients with heart
failure selected to exercise-trained and untrained groups and
dropout patients
Dropout
(n  22)
Untrained
(n  17)
Exercise trained
(n  17) P Value
Age, yr 56  2 54  2 56  2 0.70
BMI, kg/m2 28  1 27  1 27  1 0.80
Gender
Male 17(77%) 15(88%) 13(77%) 0.62
Female 5(23%) 2(12%) 4(23%)
Functional Class
NYHA-II 14(64%) 12(70%) 12(70%) 0.86
NYHA-III 8(36%) 5(30%) 5(30%)
HF etiology
Idiopathic 6(27%) 6(35%) 6(35%) 0.78
Ischemic 12(55%) 7(29%) 6(35%)
Hypertensive 2(9%) 3(18%) 3(18%)
Chagasic 2(9%) 3(18%) 2(12%)
Medications
Beta-blocker 21(95%) 17(100%) 17(100%) 0.45
ACEI/ARB 22(100%) 17(100%) 17(100%) 1.00
Spironolactone 18(82%) 14(84%) 14(84%) 0.99
Diuretics 16(73%) 14(82%) 12(71%) 0.69
ASA 12(55%) 9(53%) 9(53%) 0.99
Statins 13(59%) 10(59%) 8(47%) 0.71
Hypertension 15(68%) 12(71%) 10(59%) 0.46
Diabetes 6(27%) 4(24%) 5(29%) 0.93
Values are means  SE. BMI, body mass index; NYHA, New York Heart
Association; ACEI, angiotensin-converting enzyme inhibitors; ARB, angio-
tensin II receptor blocker; ASA, acetylsalicylic acid.
Table 2. Neurovascular and hemodynamic parameters in
heart failure patients selected to exercise-trained and
untrained heart failure groups
Dropout
(n  22)
Untrained
(n  17)
Exercise Trained
(n  17)
Pre Pre Post Pre Post
LVEF, % 33  2 29  1 31  2 28  2 32  3
Peak V˙ O2,
ml·kg1·min1
16  1 17  1 17  1 18  1 21  1*†
HR, beats/min 67  3 62  3 61  2 63  2 63  2
SBP, mmHg 136  6 131  5 136  6 130  4 126  4
DBP, mmHg 76  3 71  2 75  3 69  2 70  3
MBP, mmHg 97  4 94  3 99  4 92  3 91  3
MSNA, total activity 164  17 156  20 156  17 135  20 112  11*
MSNA, burst/min 41  3 39  2 38  2 40  2 33  2*†
MSNA, burst/100
heartbeats
61  4 64  4 64  3 65  4 54  3*†
Values are means  SE. LVEF, left ventricular ejection fraction; V˙ O2,
oxygen uptake; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic
blood pressure MBP, mean blood pressure; MSNA, muscle sympathetic nerve
activity. *P  0.05 vs. pre within group. †P  0.05 vs. untrained.
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30% MVC isometric leg exercise, the increases in diastolic BP
and HR were significantly blunted (Table 2).
Effects of Exercise Training on Muscle Metaboreflex Control
Examples of sympathetic neurograms during metaborecep-
tor stimulation pre- and postexercise training and pre- and
posttime control are shown in Fig. 3A. Before exercise training
or time control, MSNA returned to resting levels during PECA
in both groups (Fig. 4), consistent with blunted metaboreflex
control. In contrast, HR and BP were significantly increased in
relation to rest period during PECA in both groups (Table 3).
After exercise training, the changes in MSNA were augmented
during PECA and this increase was significantly greater than
the changes in MSNA in the untrained time control HF group
(Fig. 4, A–C), in which, MSNA once again returned to resting
levels during PECA. In contrast, the increase in HR and BP
during PECA was unchanged pre- and posttime in the exercise-
trained group (Table 3). There were no technical problems with
the nerve recording during PECA.
Effects of Exercise Training on Muscle Mechanoreflex
Control
Examples of sympathetic neurograms during mechanorecep-
tor activation pre- and postexercise training and pre- and
posttime control are shown in Fig. 3B. Passive exercise, which
stimulates the mechanoreflex, provoked a significant and sim-
ilar increase in MSNA and diastolic and mean BP in both
exercise-trained and untrained groups (Fig. 4, D–F; Table 3).
There were no significant increases in systolic BP and HR in
peak passive exercise. After exercise training, the increase
in MSNA was reduced and significantly less than the increase
in MSNA in the untrained time control group (Fig. 4, D–F),
consistent with a significant decrease in mechanoreflex sensi-
tivity. Similarly, after exercise training, the increase in dia-
stolic and mean BP was less than the increase in the untrained
time control group (Table 3). The systolic BP and HR re-
sponses pre- and posttime in exercise-trained group were
unchanged (Table 3). Nerve recording amplitude abruptly
decreased during the experimental protocol in one exercise-
trained patient consistent with a change in microelectrode
position. This patient was excluded from the data analysis.
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Fig. 2. Peak of 30% isometric leg exercise in untrained and exercise-trained
heart failure patients. A: muscle sympathetic nerve activity (MSNA) total
activity (a.u.). B: MSNA frequency (bursts/min). C: MSNA incidence [bursts/
100 heartbeats (HB)]. *P 0.05 vs. pre within group. †P 0.05 vs. untrained.
‡P  0.05 vs. rest.
Table 3. Hemodynamic responses during peak of 30%
isometric leg exercise, postexercise regional circulatory
arrest, and peak of passive exercise stimulation in untrained
and exercise-trained heart failure patients
Untrained Exercise Trained
Pre Post Pre Post
Peak of 30% leg exercise (n  17) (n  16)
HR, % 19  2‡ 17  2‡ 15  3‡ 8  1*†‡
SBP, % 7  2‡ 8  2‡ 7  1‡ 7  2‡
DBP, % 13  3‡ 12  2‡ 11  2‡ 7  1*‡
MBP, % 11  3‡ 11  2‡ 10  2‡ 8  1‡
PECA (n  17) (n  16)
HR, % 10  3‡ 9  2‡ 6  1‡ 7  1‡
SBP, % 7  2‡ 7  1‡ 5  1‡ 7  1‡
DBP, % 9  2‡ 7  2‡ 5  1‡ 7  1‡
MBP, % 9  2‡ 8  2‡ 6  1‡ 8  1‡
Peak of passive exercise (n  17) (n  15)
HR, % 1  1 1  1 1  1 0  1
SBP, % 1  1 1  0.5 1  1 1  1
DBP, % 1  1‡ 1  0.5 2  1‡ 0  1†
MBP, % 1  1‡ 2  1‡ 2  1‡ 0  1‡†
Values are means  SE. PECA, postexercise circulatory arrest. *P  0.05
vs. pre within group. †P  0.05 vs. untrained. ‡P  0.05 vs. rest.
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Effects of Exercise Training on Skeletal Muscle–Muscle
Metaboreflex Control
TRPV1 and CB-1 receptors. Exercise training significantly
increased gene expression of the TRPV1 receptor (Fig. 5A) and
gene expression of the CB1 receptor (Fig. 5B) in the VL
muscle. No changes were observed in gene expression of the
TRPV1 receptor and CB1 receptor in untrained HF patients.
The comparisons between groups posttraining or posttime
control showed that gene expression of the TRPV1 receptor
(Fig. 5A) and CB1 receptor (Fig. 5B) was significantly higher
in exercise-trained HF patients when compared with untrained
HF patients.
Effects of Exercise Training on Skeletal Muscle–Muscle
Mechanoreflex Control
COX pathway enzymes. COX-1 and COX-2 are rate-limiting
enzymes in the formation of prostaglandins (42). Exercise
training caused no significant changes in gene expression of
COX-1 in the VL muscle (Fig. 6A). In contrast, exercise
training tended to reduce gene expression of COX-2 in the VL
muscle (P  0.08; Fig. 6B). No significant changes in gene
expression of COX-1 and COX-2 were found in the untrained
patients. The comparisons between groups posttraining or
posttime control showed that gene expression of COX-2 was
significantly lower in exercise-trained HF patients compared
with untrained HF patients (Fig. 6B). Importantly, protein
levels of COX-2 were significantly reduced following exercise
training compared with baseline in the exercise-trained HF
group (Fig. 6C) but were unchanged pre- and posttime control
period in untrained HF patients. The comparisons between
groups posttraining or posttime control showed that protein
levels of COX-2 were significantly lower in exercise-trained
HF patients compared with untrained HF patients (Fig. 6C).
COX-2 transforms arachidonic acid into prostaglandin H2,
which is rapidly transformed by the downstream enzymes
mPGES1, PGIS, or TXAS into the COX-2 products prosta-
glandin E2 (PGE2), prostacyclin (PGI2), and thromboxane A2
Rest 20 s PE 20 s
Untrained – Pre (male, 53years) 
Rest 20 s PE 20 s
Untrained – Post
Rest 20 s PE 20 s
Exercise-trained – Pre (male, 53years) 
Rest 20 s PE 20 s
Exercise-trained - Post
Mechanoreflex Sensitivity
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Untrained – Post
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Exercise-trained - Post
Metaboreflex Sensitivity
A
B
Fig. 3. Sympathetic neurograms of untrained and exercise-trained heart failure patients during metaboreceptors stimulation (A) and during mechanoreceptors
stimulation (B).
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(TXA2), respectively (42). There were no changes in the
expression of any of these downstream enzymes in the exer-
cise-trained or untrained HF patients (data not shown).
Regulation of COX-2 expression. We then investigated pos-
sible mechanisms by which the COX-2 expression might be
decreased following exercise training in HF patients. Proin-
flammatory cytokines induce COX-2 expression in response to
inflammation (42). In this process, inactive cytoplasmic NF-B
is released from IB-, allowing NF-B to enter the nucleus
and increase expression of COX-2. In the present study, the
ratio of NF-B/IB- was increased in the untrained HF
patients during time control (Fig. 7D), but this increase was not
seen in the exercise-trained patients, indicative of relative
decrease in inflammation and NF-B translocation to the nu-
cleus. The miRNA-146 expression, which acts through a neg-
ative feedback loop to decrease NF-B (37), was significantly
increased after exercise training (Fig. 7C) but not in the time
control HF group. The expression of miRNA-16 and miRNA-
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143, which regulate COX-2, was unchanged pre- and posttrain-
ing and during the pre- and posttime control period (Fig. 7, A
and B).
COX-2 pathway receptors. We then compared the gene
expression of receptors for the COX-2 metabolites EP1, EP2,
EP3, EP4, IP, and TP. Exercise training significantly reduced
gene expression of the EP4 receptor (1.0 vs. 0.70 AU) and gene
expression of TP receptor (1.0 vs. 0.65 AU) in the VL muscle
pre- and posttraining period but caused no significant changes
in any other receptor. No changes were found in the untrained
HF patients. Furthermore, the comparisons between groups
posttraining or posttime control showed that gene expression of
EP4 receptor was significantly lower in exercise-trained HF
patients compared with untrained HF patients.
DISCUSSION
In patients with HF from systolic dysfunction and in animal
models of HF, the exercise pressor reflex is augmented during
exercise and has been shown to be associated with attenuated
muscle metaboreflex control of MSNA and augmented muscle
mechanoreflex control of MSNA (13, 18, 21, 22, 25, 39–41,
45, 49). In fact, the two seem to be inversely, and perhaps
causally, related, since in healthy animal models in which the
metaboreceptors are selectively destroyed, the mechanorecep-
tors develop heightened sensitivity (13, 39, 40). In humans
with HF, the “muscle hypothesis” has been advanced, which
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posits that abnormalities of the skeletal muscle underlie the
abnormal reflex neurovascular responses evoked during exer-
cise and thus the diminished exercise capacity in HF (7, 32).
Importantly, in animal models of HF, exercise training pre-
vents the development of abnormal muscle afferent sensitivity
and decreased exercise pressor reflex (46, 47).
The main, new findings of the present study are 1) in HF
patients, exercise training increases muscle metaboreflex con-
trol of MSNA, which is accompanied by an increase in expres-
sion of TRPV1 and CB1 receptors. 2) In HF patients, exercise
training decreases the muscle mechanoreflex control of
MSNA, which is accompanied by a decrease in expression of
COX-2, EP4 receptors, TP receptors, and the ratio of NF-B/
IB- and an increase in miRNA-146 in skeletal muscle. 3)
The net effect of exercise training on these reflex systems is an
increase in MSNA during 30% MVC isometric leg exercise,
which is not accompanied by an increase in BP or HR; in fact,
the changes in these hemodynamic parameters provoked by
exercise tend to be decreased following exercise training.
These findings support the concept, advanced by the muscle
hypothesis (7, 32), that abnormalities in the skeletal muscle
underlie the abnormal reflex responses during exercise in
humans with HF and, most importantly, suggest that these
abnormalities are reversible.
Several independent groups have reported that, in the rat-
infarct model of HF, the muscle metaboreflex is attenuated and
is associated with decreased expression of TRPV1 receptors
(20, 40, 45, 49). Furthermore, this decreased group IV fiber
responsiveness and decreased TRPV1 receptor density is not
due to selective cell death or necrosis, since examination of the
DRG does not reveal evidence of apoptosis or necrosis (13,
49). In our study in humans, the reversal of the attenuation of
muscle metaboreflex control of MSNA accompanied by an
increase in the expression of the TRPV1 receptor with exercise
training further refute apoptosis and necrosis as the underlying
mechanisms. Conversely, an abnormality related to the skeletal
myopathy of HF is consistent with our finding of improvement
with exercise training, since exercise training also reverses the
skeletal myopathy (44). TRPV1 receptors depend on nerve
growth factor (NGF), which is expressed in healthy skeletal
muscle and binds to presynaptic terminals in IV afferents to
upregulate TRPV1 receptor expression and sensitization (13,
50, 51, 53). NGF, which originates in the healthy skeletal
muscle, has been found to be decreased in the DRG in the
rat-infarct model of HF, reflective of abnormal skeletal muscle
NGF content and potentially underlying the attenuated muscle
metaboreflex (13, 50, 51, 53). The level of NGF in skeletal
muscle in humans with HF before and after training has not yet
been measured, but is an area of active investigation in our
laboratory. Interestingly, TRPV1 receptors are colocalized
with CB1 receptors and have been found to have decreased
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expression in the rat-infarct model of HF (49). We found that
CB1 expression was increased following training. The role in
NGF in CB1 expression and activity is unknown (53).
Just as several independent groups have reported attenuated
muscle metaboreflex sensitivity in the rat infarct model, in-
creased muscle mechanoreflex sensitivity in this HF model has
also been widely reported (18, 20, 29, 40, 45). Similarly, we
previously reported that in humans with HF, muscle mechan-
oreflex-mediated increases in MSNA were augmented, and this
augmentation was inhibited by indomethacin, consistent with
the notion that COX products sensitize muscle mechanorecep-
tors in humans with HF (21, 22). The present study extends
these findings. The findings in the present study that, following
exercise training, the muscle mechanoreflex-mediated increase
in MSNA is significantly diminished, and this decrease is
accompanied by a significant decrease in COX-2 expression in
the VL muscle, support the notion that overexpression of
COX-2 in the skeletal muscle of HF patients leads to increased
prostaglandin (likely PGE2) sensitization of group III afferents.
The expression of the EP4 receptor, which is present on DRG
and is responsible for afferent nerve sensitization by PGE2
(52), is also decreased following exercise training. Similarly,
the expression of the TP receptor, which is responsible for the
afferent sensitization by TXA2 is decreased following exercise
training. In summary, either the increase in COX-2 expression
leading to increased PGE2 and TXA2, or the increase in
afferent EP4 and TP receptors that sensitive group III afferents,
or both contribute significantly to the augmented muscle mech-
anoreceptor sensitivity in humans with HF.
What is the mechanism increasing the COX-2 expression in
VL muscle in untrained HF patients? Interestingly, the mech-
anism underlying the augmented COX-2 expression can also
be traced back to the skeletal myopathy of HF. Expression of
COX-2 is augmented by increased inflammation in skeletal
muscle and mediates further inflammation (42). In this study,
exercise training prevented the increase in the NF-B/IB ratio
seen the untrained time control group, a marker of active
inflammation, which may be associated with the increase in
miRNA-146. In addition, exercise training decreased the ex-
pression of the COX-2, EP4, and TP receptors, consistent with
improvement in the skeletal myopathy of HF. Other studies in
humans with HF, or the rat-infarct model, have also demon-
strated an anti-inflammatory effect of exercise training (5, 14).
In humans with HF, these findings of abnormal muscle
afferent activity during exercise, accompanied by evidence of
inflammation (NF-B, COX-2) and decreased expression of
afferent receptors (TRPV1, CB1), all of which reverse with
exercise training, are strongly supportive of the muscle hypoth-
esis of exercise dysfunction. Furthermore, the striking finding
that resting MSNA levels are markedly decreased following
exercise training is consistent with the concept that abnormal
signals originating in skeletal muscle and muscle afferents are
important contributors to the resting sympathetic excitation
that characterizes chronic HF with systolic dysfunction in
humans.
It was somewhat surprising that the MSNA response to 30%
MVC isometric leg exercise was augmented following exercise
training. This augmented MSNA response must, in part, be
attributable to the muscle metaboreflex, since exercise training
increased the muscle metaboreflex sensitivity. Our findings
that expression of TRPV1 and CB1 receptors was increased
following exercise training further support an important role
for the muscle metaboreflex in mediating the exercise-induced
increase in MSNA in trained HF patients. Interestingly, this
increase in MSNA was not accompanied by exaggerated or
augmented changes in BP or HR during the isometric exercise.
We did not measure sympathetic activity to other organs and
tissues, such as the heart or kidney. It remains possible that
following training, sympathetic responses provoked by exer-
cise directed to these organs actually decreased, explaining the
minimal hemodynamic effects. Our findings suggest that the
alteration in muscle metaboreflex and mechanoreflex control of
MSNA may also play a role in the reduction in resting MSNA
following exercise training in HF patients. However, we cannot
rule out other beneficial effects of exercise training on MSNA,
including effects on the arterial baroreflex and central integra-
tion on resting MSNA levels.
Limitations
We recognize limitations in our study. Although the maneu-
vers to isolate individual afferent limbs of the exercise pressor
reflex have been used for decades, it is likely they are not pure.
For example, PECA may also stimulate of the nociceptive
fibers and cause pain. To address this possibility, circulatory
arrest without previous exercise was conducted in three HF
patients to detect the effect, if any, on efferent MSNA. We
found no significant changes in MSNA under this condition
(data not shown). Furthermore, no HF patient complained of
pain during this PECA maneuver, which was completed in all
study participants. HF patients were taking medications that
could not be stopped for ethical reasons but that could theo-
retically alter hemodynamic and neural responses to exercise.
Medications may explain the absence of significant increases in
hemodynamic (e.g., HR and BP) responses during exercise,
despite the increased sympathetic responses. MSNA responses
may be less affected by medications; in fact, acute administra-
tion of beta-adrenergic blockers in HF patients has been re-
ported to have no effect on MSNA (3). It is worth noting that
medication doses remained stable throughout the study period,
so medication changes are unlikely to underlie changes in
sympathetic responses following exercise training. Approxi-
mately half the HF patients were taking aspirin, which inhibits
COX-1 and COX-2 activity. Aspirin administration does not
explain our findings, since aspirin use was not different be-
tween the trained and untrained HF groups (Table 1). Further-
more, when the data were reanalyzed according to aspirin use,
the results were unchanged (data not shown). Although the
COX pathway is an important pathway in contributing the
increased SNA responses during exercise in HF, it is unlikely
the only one. In the rat-infarct model, the P2X receptor is
upregulated on muscle group III afferents, and infusion of the
P2X antagonist attenuates the exaggerated SNA response to
mechanical deformation (45). Although we did not investigate
the role of the P2X receptor in mediating the exaggerated
MSNA responses during mechanoreflex stimulation our HF
patients, the data in the rat infarct model are strong, and the
P2X receptor warrants investigation in humans with HF as
well. The muscle biopsy included neuronal, vascular, muscu-
lar, and connective tissue, so the tissue of origin of the TRPV1
and CB1 receptors in the muscle homogenate, although most
likely neuronal, cannot be stated unequivocally. Finally, we did
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not include a healthy control group. A control group of healthy
age-matched volunteers would provide important information
about the normal levels of TRPV1 and CB1 in the absence of
HF. The literature available in animals may not reflect what
occurs in humans. Furthermore, our study does not clarify how
the exercise-induced increase in TRPV1 and CB1 levels in HF
relates to the situation in healthy controls. Interestingly, in
healthy volunteers, Ray et al. (35) reported that MSNA did not
increase during 30% MVC intensity isometric leg exercise, but
did increase during 30% MVC intensity isometric arm exer-
cise. In contrast, we found that MSNA does increase signifi-
cantly during 30% MVC isometric leg exercise in untrained HF
patients. Ray et al. studied healthy young males, ages 19–29
yr, whereas our cohort of HF patients was 30 yr older and
included females. Although the stated purpose of our study was
to determine the effect of exercise training on neuronal reflexes
in HF patients, future studies of MSNA responses during 30%
MVC leg exercise in healthy middle-aged men and women
would be of interest.
In conclusion, exercise training improves muscle metabore-
flex and mechanoreflex control of MSNA in humans with HF.
This exercise training-induced improvement in reflex control
of MSNA is accompanied by augmented TRPV1 and CB1
expression, reduction of COX-2 expression, and reduced in-
flammation in skeletal muscle. These findings strongly support
the concept that abnormalities in the skeletal muscle itself
underlie the abnormal reflex control of SNA during exercise in
HF, that is, the “muscle hypothesis.” Nonetheless, our results
call into question the role of augmented MSNA levels during
exercise in limiting exercise capacity in HF patients. Despite
the increased exercise capacity following exercise training in
our HF patients, MSNA responses during exercise were sig-
nificantly augmented in these exercise-trained HF patients.
Furthermore, augmented MSNA responses were not accompa-
nied by greater increases in hemodynamic responses (HR and
BP) during exercise. Thus in pharmacologically optimized HF
patients, decreased exercise capacity may not be attributable to
abnormalities of reflex sympathetic activation but may be
mediated by other mechanisms, also rooted in the skeletal
muscle, such as abnormalities in calcium cycling in skeletal
muscle, which warrant future investigation (26). Importantly,
elevated resting MSNA levels in HF, a marker of increased
mortality, were markedly decreased following training. These
findings provide strong support for the recommendation of
exercise training in all patients with chronic HF.
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